E
IDXX icon

Ergoteles’s Idexx Laboratories IDXX Stock Holding History

Ergoteles’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,465
Closed -$736K – 420
2023
Q2 		$736K Buy
1,465
+569
+64% +$273K 0.04% 545
2023
Q1 		$448K Sell
896
-4,649
-84% -$2.22M 0.02% 775
2022
Q4 		$2.26M Buy
5,545
+3,441
+164% +$1.34M 0.08% 248
2022
Q3 		$685K Sell
2,104
-25,389
-92% -$9.33M 0.02% 645
2022
Q2 		$9.64M Buy
27,493
+24,124
+716% +$9.84M 0.29% 92
2022
Q1 		$1.84M Buy
+3,369
New +$1.77M 0.07% 276
2021
Q4 		– Sell
-54,397
Closed -$33.8M – 1405
2021
Q3 		$33.8M Buy
54,397
+52,292
+2,484% +$35.1M 1.24% 10
2021
Q2 		$1.33M Buy
+2,105
New +$1.16M 0.03% 438
2020
Q4 		– Sell
-1,000
Closed -$393K – 785
2020
Q3 		$393K Buy
+1,000
New +$370K 0.05% 277

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Ergoteles's IDXX Position: Q3 2023 in Review

Ergoteles sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 1,465 shares — an estimated $736K sold.

Ergoteles first reported a position in IDXX in Q3 2020 and held it in 9 quarters. The position peaked at $33.8M in Q3 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Ergoteles reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 1,465 Idexx Laboratories shares in Q3 2023, an estimated $736K.
  • Ergoteles first reported a position in Idexx Laboratories in Q3 2020 and held it in 9 quarters.
  • Ergoteles's Idexx Laboratories position peaked at $33.8M in Q3 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.